US 12152071
EGFL6 specific monoclonal antibodies and methods of their use
granted A61KA61K2039/505A61K9/0019
Quick answer
US patent 12152071 (EGFL6 specific monoclonal antibodies and methods of their use) held by The Board of Regents of the University of Texas System expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Nov 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2039/505, A61K9/0019, A61P, A61P35/00